Results 111 to 120 of about 351,379 (204)

Prostate-specific antigen testing and prostate cancer-related outcomes: a Danish nationwide study. [PDF]

BJU Int
Palshof FK, Mørch LS, Brasso K, Kroman N, Larsen SB, Røder A, Stroomberg HV.   +6 more
europepmc   +1 more source

Diagnostic accuracy of prostate-specific antigen and prostate-specific antigen density in patients suspected of having prostate cancer in South Korea: A large, multi-institutional registry. [PDF]

Investig Clin Urol
Yun JE, Lee KS, Lee H, Lee SH, Jung JH, Hwang EC, Lee NR, Han WK, Yu SY.   +8 more
europepmc   +1 more source

Incidence and oncologic outcomes of patients with prostate-specific antigen persistence after radical prostatectomy. [PDF]

Cancer
Lane BR, Lewicki P, Noyes SL, Labardee C, Meah S, Daignault-Newton S, Hafron J, Morgan TM, Radhakrishnan A, Dess RT, Montie J, Ghani KR, Ginsburg KB, Borza T.   +13 more
europepmc   +1 more source

Prostate Specific Antigen Ordering After Implementation of a Point-of-Care Reminder to Discuss Screening. [PDF]

J Am Board Fam Med
Fenton JJ, Tancredi DJ.
europepmc   +1 more source

Correlating Histological Results and Total Serum Levels of the Prostate-Specific Antigen Among Patients in Southwestern Uganda. [PDF]

Prostate Cancer
Nabaasa S, Mutakooha MM, Amadile L, Bagenda CN, Ninsiima JL, Birungi A, Atwine R, Wasswa H, Kasadha R, Lauben T, Ssedyabane F.   +10 more
europepmc   +1 more source

Evaluation of the Patient Acceptability of Automated Communication of Prostate-specific Antigen Results After Local Treatment for Prostate Cancer. [PDF]

Eur Urol Open Sci
Paulino Pereira LJ, Leenarts H, van Melick HHE, Sedelaar MJPM, Bruins Slot AS, van den Bergh RCN.   +5 more
europepmc   +1 more source

Radiographic Progression With and Without Prostate-Specific Antigen Rise in Patients With Advanced Prostate Cancer Treated With Enzalutamide. [PDF]

J Clin Oncol
Armstrong AJ, Azad AA, Iguchi T, Stenzl A, Mottet N, Russell D, Rosales M, Haas GP, Saad F, Hussain M, Sternberg CN.   +10 more
europepmc   +1 more source

From prostate specific antigen to genomic signatures: Advances in biomarkers for prostate cancer diagnosis and prognosis. [PDF]

Transl Oncol
Hamed NW, Elbeljihy HS, Hussin SA, Fouda RM, Oy EK, W Magar R.   +5 more
europepmc   +1 more source

Combining Multiparametric Magnetic Resonance Imaging and Prostate-Specific Antigen Density in Selecting Patients for Prostate Biopsy. [PDF]

Cureus
Derimachkovski G, Georgiev G, Draginov K, Petkov B, Rumenov V, Stoilov D, Tomov Y, Vasilev V, Yanev K.   +8 more
europepmc   +1 more source

Real-world comparative effectiveness of apalutamide versus enzalutamide for prostate-specific antigen response in metastatic castration-sensitive prostate cancer. [PDF]

Ther Adv Med Oncol
Bilen MA, Lowentritt BH, Burbage S, Patel C, Rossi C, Kinkead F, Wong G, Pilon D, Shore ND.   +8 more
europepmc   +1 more source